These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 6289564)
1. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon]. Baumgärtner M; Grehn M; Wundt W Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564 [TBL] [Abstract][Full Text] [Related]
2. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)]. Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385 [TBL] [Abstract][Full Text] [Related]
3. [Efficacy of the new cephalosporin antibiotics cefotaxime, cefoperazone and lamoxactam]. Pulverer G; Peters G Med Welt; 1982 Apr; 33(17):642-4. PubMed ID: 6285119 [No Abstract] [Full Text] [Related]
4. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin. Braveny I; Machka K; Elsser R Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of ceftazidime and ceftriaxone. Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195 [TBL] [Abstract][Full Text] [Related]
6. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins. Mouton RP; Bongaerts GP; van Gestel M; Bruggeman-Ogle KM Chemotherapy; 1981; 27(5):318-24. PubMed ID: 6455258 [TBL] [Abstract][Full Text] [Related]
7. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains]. Mascellino MT; Prignano G; Iegri F; Lorenzi A Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234 [TBL] [Abstract][Full Text] [Related]
8. Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters. Verbist L Arzneimittelforschung; 1981; 31(6):982-6. PubMed ID: 6266430 [TBL] [Abstract][Full Text] [Related]
9. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins]. Baumgärtner M; Dickgiesser N; Müller S; Wundt W Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa. Livermore DM; Williams RJ; Williams JD J Antimicrob Chemother; 1981 Oct; 8(4):323-31. PubMed ID: 6271726 [No Abstract] [Full Text] [Related]
11. Comparative in vitro activity and beta-lactamase stability of moxalactam and other selected cephalosporin antibiotics. Vuye A Arzneimittelforschung; 1981; 31(8):1290-5. PubMed ID: 6457607 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials. Jones RN; Wilson HW Diagn Microbiol Infect Dis; 1983 Mar; 1(1):71-83. PubMed ID: 6323095 [TBL] [Abstract][Full Text] [Related]
13. [In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study]. Duval J; Soussy CJ; Deforges L; Le Van Thoi J; Acar JF; Kitzis D; Dabernat H; Christol D; Bure A; Courtieu AL Pathol Biol (Paris); 1983 May; 31(5):357-61. PubMed ID: 6312397 [TBL] [Abstract][Full Text] [Related]
14. In vitro microbiological properties of mezlocillin compared with four cephalosporins. Esposito S; Galante D; Barba D Chemioterapia; 1986 Aug; 5(4):273-7. PubMed ID: 3490314 [TBL] [Abstract][Full Text] [Related]
15. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime]. Le Noc P; Bryskier A; Le Noc D Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396 [TBL] [Abstract][Full Text] [Related]
16. Ceftriaxone - a new broad-spectrum semisynthetic cephalosporin. In vitro activity against gram-negative bacilli sensitive and resistant to gentamicin. Bremner DA Chemotherapy; 1983; 29(4):283-8. PubMed ID: 6307605 [TBL] [Abstract][Full Text] [Related]
17. In vitro activity of a new semisynthetic cephalosporin: cefoperazone. Auckenthaler R; Waldvogel FA Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401 [TBL] [Abstract][Full Text] [Related]
18. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime]. Le Noc P; Bryskier A; Le Noc D Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972 [TBL] [Abstract][Full Text] [Related]
19. Bactericidal activity of cefoperazone in comparison with other beta-lactam antibiotics and gentamicin. Welch DF; Matsen JM Clin Ther; 1980; 3(Spec Issue):127-9. PubMed ID: 6446385 [TBL] [Abstract][Full Text] [Related]
20. Comparative activity of ceftizoxime and four other cephalosporins against gram negative bacteria and their sensitivity to beta-lactamases. Esposito S; Galante D; Barba D; Pennucci C; Limauro D Microbiologica; 1985 Apr; 8(2):197-204. PubMed ID: 3874342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]